Features

Hoya Reports Record High Revenues in Third Quarter Results

During the quarter, which ended December 31, 2017, HOYA Group reports that revenues increased 11.6 % year on year, reaching 136,759 million yen.

Motivating Staff in an Optometrist’s Office

How do you attract, grow and keep exceptional staff?

Gene Therapy for Vision Loss Approved by FDA

A gene therapy treatment for the disease known as “biallelic RPE65 mutation-associated retinal dystrophy,” a rare condition with onset in childhood or adolescence that leads to complete vision loss, was approved by the FDA in December of 2017.

Engineer at Simon Fraser Develops High Resolution Retinal Scanner

Marko Sarunic, Engineering Science Professor at Simon Fraser University, has developed a high resolution retinal scanner that can help in diagnosing disease before vision loss occurs.

Essilor Shares Rise Sharply in Past Month

Essilor’s stock price has been on the rise in the last 4 weeks, increasing 5.97% in that span.

Hoya Reports Record High Revenues in Third Quarter Results

During the quarter, which ended December 31, 2017, HOYA Group reports that revenues increased 11.6 % year on year, reaching 136,759 million yen.

Motivating Staff in an Optometrist’s Office

How do you attract, grow and keep exceptional staff?

Gene Therapy for Vision Loss Approved by FDA

A gene therapy treatment for the disease known as “biallelic RPE65 mutation-associated retinal dystrophy,” a rare condition with onset in childhood or adolescence that leads to complete vision loss, was approved by the FDA in December of 2017.

Engineer at Simon Fraser Develops High Resolution Retinal Scanner

Marko Sarunic, Engineering Science Professor at Simon Fraser University, has developed a high resolution retinal scanner that can help in diagnosing disease before vision loss occurs.

Essilor Shares Rise Sharply in Past Month

Essilor’s stock price has been on the rise in the last 4 weeks, increasing 5.97% in that span.

Hoya Reports Record High Revenues in Third Quarter Results

During the quarter, which ended December 31, 2017, HOYA Group reports that revenues increased 11.6 % year on year, reaching 136,759 million yen.

Motivating Staff in an Optometrist’s Office

How do you attract, grow and keep exceptional staff?

Gene Therapy for Vision Loss Approved by FDA

A gene therapy treatment for the disease known as “biallelic RPE65 mutation-associated retinal dystrophy,” a rare condition with onset in childhood or adolescence that leads to complete vision loss, was approved by the FDA in December of 2017.

Engineer at Simon Fraser Develops High Resolution Retinal Scanner

Marko Sarunic, Engineering Science Professor at Simon Fraser University, has developed a high resolution retinal scanner that can help in diagnosing disease before vision loss occurs.

Essilor Shares Rise Sharply in Past Month

Essilor’s stock price has been on the rise in the last 4 weeks, increasing 5.97% in that span.

Hoya Reports Record High Revenues in Third Quarter Results

During the quarter, which ended December 31, 2017, HOYA Group reports that revenues increased 11.6 % year on year, reaching 136,759 million yen.

Motivating Staff in an Optometrist’s Office

How do you attract, grow and keep exceptional staff?

Gene Therapy for Vision Loss Approved by FDA

A gene therapy treatment for the disease known as “biallelic RPE65 mutation-associated retinal dystrophy,” a rare condition with onset in childhood or adolescence that leads to complete vision loss, was approved by the FDA in December of 2017.

Engineer at Simon Fraser Develops High Resolution Retinal Scanner

Marko Sarunic, Engineering Science Professor at Simon Fraser University, has developed a high resolution retinal scanner that can help in diagnosing disease before vision loss occurs.

Essilor Shares Rise Sharply in Past Month

Essilor’s stock price has been on the rise in the last 4 weeks, increasing 5.97% in that span.